11/21/2024
3:33 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
4:43 PM | Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
6:16 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/25/2024
6:19 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/25/2024
3:10 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/23/2024
4:27 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:07 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
3:15 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q/A | |
09/27/2024
3:15 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:01 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/20/2024
3:55 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
7:01 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:40 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
09/11/2024
3:01 PM | Centessa Pharmaceuticals (Filer)
| Form S-3ASR | |
09/10/2024
3:04 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
3:06 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/10/2024
6:08 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
4:06 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:12 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
4:13 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:19 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
4:15 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
3:32 PM | Centessa Pharmaceuticals (Subject)
Weinhoff Gregory M (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
3:13 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/21/2024
3:38 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:52 PM | Centessa Pharmaceuticals (Subject)
SAHA SAURABH (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
6:27 AM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:31 PM | Bush Tia L (Reporting)
Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:30 PM | Centessa Pharmaceuticals (Issuer)
ZBAR BRETT I W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:31 PM | Centessa Pharmaceuticals (Issuer)
Stuckley Carol (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:32 PM | Centessa Pharmaceuticals (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:33 PM | Centessa Pharmaceuticals (Issuer)
Hukkelhoven Mathias (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:34 PM | Centessa Pharmaceuticals (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:34 PM | Centessa Pharmaceuticals (Issuer)
GOYAL ARJUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
2024 Election Year Stocks: Uncover Hidden Gems! (Ad) In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss. Secure your copy now by clicking this link. |
06/25/2024
3:14 PM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
7:49 PM | Centessa Pharmaceuticals (Issuer)
Crowley John J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/10/2024
6:13 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:48 PM | Centessa Pharmaceuticals (Filer)
| Form DEFA14A | |
05/13/2024
3:32 PM | Centessa Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
7:00 AM | Centessa Pharmaceuticals (Filer)
| Form DEF 14A | |
05/09/2024
7:01 AM | Centessa Pharmaceuticals (Filer)
| Form ARS | |
04/24/2024
7:53 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/24/2024
8:26 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
4:16 PM | Centessa Pharmaceuticals (Filer)
| Form 424B5 | |
04/22/2024
6:15 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:17 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:15 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:16 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:44 PM | Centessa Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/26/2024
3:16 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/25/2024
3:06 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:37 PM | Centessa Pharmaceuticals (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
6:12 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
4:10 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:02 PM | Anderson Karen M. (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:03 PM | Centessa Pharmaceuticals (Issuer)
Rotman Harris (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:04 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:07 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:08 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:09 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:56 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
6:41 PM | Centessa Pharmaceuticals (Issuer)
GRAINGER DAVID J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:43 PM | Centessa Pharmaceuticals (Issuer)
SAHA SAURABH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:44 PM | Centessa Pharmaceuticals (Issuer)
HUSSAIN IQBAL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:45 PM | Centessa Pharmaceuticals (Issuer)
Weinhoff Gregory M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:46 PM | Centessa Pharmaceuticals (Issuer)
CHAO DAVID M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
6:37 PM | Bush Tia L (Reporting)
Centessa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
6:05 AM | Centessa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
